Opal Biosciences buys drug development business, eyes manufacture

Infections diseases therapy company Opal Biosciences has bought a specialist pharmaceutical formulation business, boosting its capabilities in developing new drugs for clinical trials and manufacture. The Melbourne company bought Formulytica Pty Ltd which has in-house laboratories for developing formulations for topical and injectable drugs. The company provides a fee-for-service business for local and international clients…

Softmed onshores production of surgical wrap

Australia’s largest personal protective equipment (PPE) manufacturer, Softmed, has begun producing one million sterilisation wraps per month which are used to wrap and seal surgical trays and instruments prior to surgical procedures. The company, which in August invested $30 million in a new Victorian factory, began local production in response to a critical worldwide shortage…

Quasar launches phased array satellite ground station

Space industry startup Quasar Satellite Technologies has raised $12 million to commercialise a breakthrough technology that allows ground stations to communicate with hundreds of satellites at once. With ground stations typically talking to a single satellite, Quasar’s technology based on CSIRO’s phased array research will communicate with the thousands of nanosatellites now entering low earth…